These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5993594)
1. [Studies on the therapy of hyperlipemic athersclerosis and liver epithelial fatty degeneration with beta-pyridylcarbinol]. Zeller W; Schön H; Wüst H; Anders U; Ammon HP Klin Wochenschr; 1966 Sep; 44(17):1022-8. PubMed ID: 5993594 [No Abstract] [Full Text] [Related]
2. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs. Lundholm L; Jacobsson L; Brattsand R; Magnusson O Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851 [No Abstract] [Full Text] [Related]
3. [Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results]. Zöllner N; Gudenzi M Med Klin; 1966 Dec; 61(50):1996-2001. PubMed ID: 5994695 [No Abstract] [Full Text] [Related]
4. [General therapy of arteriosclerosis]. Siedek H Wien Klin Wochenschr; 1969 Jun; 81(25):464-6. PubMed ID: 5809151 [No Abstract] [Full Text] [Related]
5. [Control of hyperlipemia and fatty liver degeneration with tetranicotylfructose]. Zeller W Praxis; 1966 Nov; 55(44):1273-6. PubMed ID: 6013613 [No Abstract] [Full Text] [Related]
6. [Therapy of arteriosclerosis]. Emmrich R Z Gesamte Inn Med; 1968 Jan; 23(2):28-32. PubMed ID: 4177784 [No Abstract] [Full Text] [Related]
8. [Control of fat clearance insufficiency in hyperlipemic atherosclerosis]. Zeller W; Christ F Med Klin; 1966 Jan; 61(4):136-9. PubMed ID: 5983158 [No Abstract] [Full Text] [Related]
9. [Experiences with new Cosaldon forms]. Dammann C Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023 [No Abstract] [Full Text] [Related]
10. [Effects of Alisma plantago L on hyperlipemia, atherosclerosis and fatty liver]. He XY Zhong Xi Yi Jie He Za Zhi; 1981 Oct; 1(2):114-7. PubMed ID: 6219776 [No Abstract] [Full Text] [Related]
11. [Treatment of hyperlipemia and steatosis by high doses of meso-insitol hexanicotinate]. Neuman M; Cachin M; Galian P; Charbonnier A; Pergola F Sem Ther; 1968 Dec; 44(10):660-3. PubMed ID: 5706294 [No Abstract] [Full Text] [Related]
13. [Effects of a hypoglycemic sulfonamide on the regression of lipid disorders and evolution of arterial lesions in rabbits after cessation of a cholesterol rich diet]. Marquié G; Agid R C R Seances Soc Biol Fil; 1971; 165(1):192-6. PubMed ID: 4257742 [No Abstract] [Full Text] [Related]
14. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)]. Schimert G MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098 [No Abstract] [Full Text] [Related]
15. [Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion]. Zöllner N; Gudenzi M Med Klin; 1966 Dec; 61(51):2036-40. PubMed ID: 5996572 [No Abstract] [Full Text] [Related]
16. The treatment of intermittent claudication with betapyridyl carbinol over two years. Nye ER; Macbeth WA Atherosclerosis; 1973; 17(1):95-106. PubMed ID: 4696751 [No Abstract] [Full Text] [Related]
17. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)]. Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781 [No Abstract] [Full Text] [Related]
18. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics]. Martinelli M; Albini U; Villecco A Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650 [No Abstract] [Full Text] [Related]
19. [Clinical picture of primary hyperlipidemias]. Sensing H; Schmechel H Z Arztl Fortbild (Jena); 1970 Jul; 64(14):717-20. PubMed ID: 5521802 [No Abstract] [Full Text] [Related]
20. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes]. Cucinotta D Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330 [No Abstract] [Full Text] [Related] [Next] [New Search]